Soumyadeep Bhaumik

Last updated
Soumyadeep Bhaumik
NationalityIndian
CitizenshipIndian
EducationMBBS, M.Sc, PhD (Medicine)
Alma mater Bankura Sammilani Medical College

Liverpool School of Tropical Medicine

University of New South Wales
Known forAdvocacy leading to change in National COVID-19 treatment guidelines in India; and setting up first Rapid Evidence Synthesis Unit in India
Scientific career
FieldsEvidence Synthesis, Health Policy, Snakebite,
Institutions George Institute for Global Health Public Health Foundation of India
Thesis Addressing the burden of snakebite: analysing policy prioritisation, evaluating health systems, and fostering research on treatments

Soumyadeep Bhaumik is an Indian medical doctor and public health researcher who heads the Meta-research and Evidence Synthesis Unit in George Institute for Global Health. [1] In 2021, Bhaumik and other scientists successfully advocated for the removal of convalescent plasma from COVID-19 treatment guidelines through an open letter to the Principal Scientific Advisor, Government of India. [2] [3] He is among top 2% of most cited researchers globally in field of general and internal medicine. [4] [5] Bhaumik is also Associate Editor, BMJ Global Health [6] and Academic Editor in PloS Neglected Tropical Diseases. [7]

Contents

Education

Bhaumik studied medicine in Bankura Sammilani Medical College, in West Bengal, India.[ citation needed ] He subsequently studied international public health in Liverpool School of Tropical Medicine in United Kingdom. He received his Ph.D. in medicine from University of New South Wales Sydney . [8] He received the Deans award for his PhD thesis on snakebite. [9]

Membership

Bhaumik is a life member of Indian Public Health Association, Indian Science Congress Association, and Academy of Family Physicians of India.He was Fellow of Royal Society of Arts in 2021-2022. [8]

Related Research Articles

<span class="mw-page-title-main">Zamindar</span> Indian hereditary aristocrat

A zamindar in the Indian subcontinent was an autonomous or semi-autonomous feudal lord of a zamindari. The term itself came into use during the Mughal Empire, when Persian was the official language; zamindar is the Persian for landowner. During the British Raj, the British began using it as a local synonym for "estate". Zamindars as a class were equivalent to lords and barons; in some cases they were independent sovereign princes. Similarly, their holdings were typically hereditary and came with the right to collect taxes on behalf of imperial courts or for military purposes.

In immunology, antiserum is a blood serum containing antibodies that is used to spread passive immunity to many diseases via blood donation (plasmapheresis). For example, convalescent serum, passive antibody transfusion from a previous human survivor, used to be the only known effective treatment for ebola infection with a high success rate of 7 out of 8 patients surviving.

<span class="mw-page-title-main">Neglected tropical diseases</span> Diverse group of tropical infectious diseases which are common in developing countries

Neglected tropical diseases (NTDs) are a diverse group of tropical infections that are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens, such as viruses, bacteria, protozoa, and parasitic worms (helminths). These diseases are contrasted with the "big three" infectious diseases, which generally receive greater treatment and research funding. In sub-Saharan Africa, the effect of neglected tropical diseases as a group is comparable to that of malaria and tuberculosis. NTD co-infection can also make HIV/AIDS and tuberculosis more deadly.

<span class="mw-page-title-main">Peter Hotez</span> American scientist, pediatrician, and advocate

Peter Jay Hotez is an American scientist, pediatrician, and advocate in the fields of global health, vaccinology, and neglected tropical disease control. He serves as founding dean of the National School of Tropical Medicine, Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, where he is also Director of the Texas Children's Hospital Center for Vaccine Development and Endowed Chair in Tropical Pediatrics. He also serves as a University Professor of Biology at Baylor University.

Rajpal Singh Yadav is an Indian scientist in the field of vector ecology and management. He joined the World Health Organization in 2009. He retired in 2023, as a Scientist at the Department of Control of Neglected Tropical Diseases, Geneva, Switzerland. He was a Co-Chair of the WHO Joint Action Group for the implementation of the Global Vector Control Response,. He was also Head of the WHO Pesticide Evaluation Scheme (WHOPES) for the evaluation of vector control products. During this period he reviewed research protocols and generated a global evidence base for insecticide use and pesticide management. He was also a Focal person in, the WHO secretariat for the FAO/WHO Joint Programme on Pesticide Management. The work involved collaboration with other UN and international organizations, research institutions, programmes, industry, NGOs, and other stakeholders. He is the recipient of the 2016, Lifetime Achievement Award from the Indian Association of Entomologists. He has published more than 100 scientific articles in peer-reviewed journals.

<span class="mw-page-title-main">Arturo Casadevall</span> Cuban-American scientist

Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and the Alfred and Jill Sommer Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He is an internationally recognized expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He was elected a member of the National Academy of Sciences in 2022.

<span class="mw-page-title-main">Soumya Swaminathan</span> Indian and WHO Deputy Director general

Soumya Swaminathan is an Indian paediatrician and clinical scientist known for her research on tuberculosis and HIV. From 2019 to 2022, she served as the chief scientist at the World Health Organization under the leadership of Director General Tedros Adhanom Ghebreyesus. Previously, from October 2017 to March 2019, she was the deputy director general of programmes (DDP) at the World Health Organization.

<span class="mw-page-title-main">Vikram Patel</span>

Vikram Harshad Patel FMedSci is an Indian psychiatrist and researcher best known for his work on child development and mental disability in low-resource settings. He is the Co-Founder and former Director of the Centre for Global Mental Health at the London School of Hygiene and Tropical Medicine (LSHTM), Co-Director of the Centre for Control of Chronic Conditions at the Public Health Foundation of India, and the Co-Founder of Sangath, an Indian NGO dedicated to research in the areas of child development, adolescent health and mental health. Since 2024, he has been the Paul Farmer Professor and Chair of the Department of Global Health and Social Medicine at Harvard Medical School in Boston, where he was previously the Pershing Square Professor of Global Health and Social Medicine. He was awarded a Wellcome Trust Principal Research Fellowship in 2015. In April 2015, he was listed as one of the world's 100 most influential people by TIME magazine.

Gagandeep Kang FRS is an Indian microbiologist and virologist who has been leading the work on enteric diseases, diarrheal infections and disease surveillance at the Bill & Melinda Gates Foundation since 2023.

<span class="mw-page-title-main">Oriol Mitjà</span> Catalan researcher

Oriol Mitjà i Villar is a Catalan-born Spanish researcher and consultant physician in internal medicine and infectious diseases with expertise in poverty-related tropical diseases. He has conducted research at the Lihir Medical Centre in Papua New Guinea since 2010 on new diagnostic and therapeutic tools to eradicate yaws. He was awarded the Princess of Girona Award in the scientific research category. Currently at the Germans Trias i Pujol Research Institute, Mitjà is conducting research on SARS-CoV-2 coronavirus disease (COVID-19) and strategies to control the infection at a community level.

<span class="mw-page-title-main">Dipyaman Ganguly</span>

Dipyaman Ganguly is an Indian physician-scientist immunologist and cell biologist, currently a principal scientist and Swarnajayanthi Fellow at the CSIR-Indian Institute of Chemical Biology (IICB). He heads the Dendritic Cell Laboratory of IICB, popularly known as the Ganguly Lab, where he hosts several researchers involved in research on regulation of innate Immunity and pathogenesis of inflammatory disorders. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2022.

Anushka Patel is and Australian cardiologist who is Chief Executive Officer at The George Institute for Global health, a Professor of Medicine at the University of New South Wales, and Cardiologist at the Royal Prince Alfred Hospital.

<span class="mw-page-title-main">Jocalyn Clark</span>

Jocalyn Clark is a Canadian Public Health Scientist and the International Editor of The BMJ, with responsibility for strategy and internationalising the journal's content, contributors and coverage. From 2016 to 2022, Jocalyn was an Executive Editor at The Lancet, where she led the Commentary section, coordinated peer review, and edited and delivered collections of articles and Commissions on topics such as maternal and child health, oral health, migration, end of life care and gender equity. She led the Lancet's project to advance women in science, medicine, and global health, #LancetWomen. She is also an adjunct professor of Medicine at the University of Toronto and an Honorary Associate Professor at the Institute for Global Health at UCL.

Neglected tropical diseases in India are a group of bacterial, parasitic, viral, and fungal infections that are common in low income countries but receive little funding to address them. Neglected tropical diseases are common in India.

<span class="mw-page-title-main">David Molyneux</span> British parasitologist (born 1943)

David Hurst Molyneux CMG is a British parasitologist who served as the director of the Liverpool School of Tropical Medicine (1991–2000), where, as of 2018, he is an emeritus professor. He previously held the Chair of Biological Sciences at the University of Salford (1977–91), where he also served as Dean of the Faculty of Science. His research and advocacy have focused on what are now known as neglected tropical diseases, and Michael Barrett credits him as among the earliest advocates of the campaign to focus international attention on this group of diseases in the early-to-mid 2000s.

The eradication of lymphatic filariasis is the ongoing attempt to eradicate the Filarioidea worms which cause the disease lymphatic filariasis and also treat the people who already have the infection.

Gavin Mark Yamey is a British-American physician and global health researcher. He is the director of the Center for Policy Impact in Global Health at Duke University and a professor of the practice of global health and public policy.

Nilima Arun Kshirsagar is an Indian clinical pharmacologist who developed and patented liposomal amphotericin B and its drug delivery system in 1993. She is the former dean of King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College. She is the national chairperson in clinical pharmacology at Indian Council of Medical Research (ICMR) and president of the South Asian chapter of the American college of clinical pharmacology. She is a Member of the WHO Committees on Product development and Drug statistics Methodology.

Madhukar Pai is a Canadian medical doctor, academic, advocate, writer, and university professor. He is the Associate Director of the McGill International Tuberculosis Centre. Pai's work focuses on global health, specifically advocacy for better treatment for tuberculosis with a focus on South Africa and India. Pai is the inaugural Chair of the Department of Global and Public Health in the School of Population and Global Health and holds a Canada Research Chair in Epidemiology and Global Health at McGill University.

<span class="mw-page-title-main">Paul Garner (doctor)</span> British epidemiologist

Paul Garner is a British epidemiologist and public health professional, known for his work in systematic reviews and evidence-informed policy. He is currently an Emeritus Professor, Evidence Synthesis in Global Health, at the Liverpool School of Tropical Medicine. Previously he was a member of the WHO malaria treatment guidelines group from 2004-18.

References

  1. "George Institute for Global Health".
  2. "Scientists raise concern over 'non-scientific use of convalescent plasma for Covid patients' in India". The Indian Express. 2021-05-11. Retrieved 2023-10-18.
  3. "COVID: Public Health Experts Pen Concerns About Plasma to PSA VijayRaghavan". The Wire. Retrieved 2023-10-18.
  4. Ioannidis, John P. A.; Boyack, Kevin W.; Baas, Jeroen (2020-10-16). "Updated science-wide author databases of standardized citation indicators". PLOS Biology. 18 (10): e3000918. doi: 10.1371/journal.pbio.3000918 . ISSN   1545-7885. PMC   7567353 . PMID   33064726.
  5. "George Institute researchers having global impact".
  6. "Editorial Board BMJ Global Health".
  7. "PLOS Neglected Tropical Diseases". journals.plos.org. Retrieved 2024-01-17.
  8. 1 2 "ORCID". orcid.org. Retrieved 2023-10-30.
  9. "Dean's Award for Outstanding PhD Theses recipients announced". Inside UNSW. Retrieved 2023-10-30.